摘要
抗磷脂综合征(APS)是一种以血栓形成和(或)习惯性流产为临床特征的自身免疫性疾病。β2糖蛋白Ⅰ(β2 GPⅠ)是该病的主要抗原,抗β2 GPⅠ抗体是以β2 GPⅠ为靶抗原的自身抗体。研究表明,β2 GPⅠ及其自身抗体在 APS血栓形成的致病过程中起到重要作用。目前 APS的诊断与治疗也越来越受到人们的重视,检测抗β2 GPⅠDⅠ抗体能特异性诊断APS,分子水平的研究也成为治疗 APS的新方向。该文就β2 GPⅠ、抗β2 GPⅠ抗体与 APS的相关性进展作以综述。
Antiphospholipid syndrome (APS)is an autoimmune multisystem disorder characterized clinically by recurrent thrombosis and pregnancy morbidity.β2-glycoproteinⅠ (β2GPⅠ)is the major antigen in the APS.Anti-β2GPⅠ antibody is the autoantibody which targets toβ2GPⅠ.There is overwhelming evidence thatβ2GPⅠand anti-β2GPⅠ antibody play an important role in the pathogenesis of APS.Now the diagnosis and treatment of anti-β2GPⅠ antibody are more and more get people's attention,detection of anti-β2GPⅠDⅠ antibody can specifically diagnose APS and research of the molecular level may provide a new therapeutic target for APS.In this paper,β2GPⅠ,anti-β2GPⅠ antibody and APS associated development were reviewed.
出处
《现代检验医学杂志》
CAS
2015年第1期19-22,共4页
Journal of Modern Laboratory Medicine
基金
国家自然科学基金(编号:81270394).